SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-025153
Filing Date
2014-06-27
Accepted
2014-06-27 16:56:00
Documents
1
Period of Report
2014-06-27

Document Format Files

Seq Description Document Type Size
1 ANNUAL OPTION GRANT rrd412168.html 4  
1 ANNUAL OPTION GRANT rrd412168.xml 4 4320
  Complete submission text file 0001181431-14-025153.txt   5687
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Issuer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2525 DUPONT DRIVE IRVINE CA 92612
Business Address
Endicott David J. (Reporting) CIK: 0001532133 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33415 | Film No.: 14946547